Machine learning uncovers potent immunomodulators for vaccines and immunotherapy

Small molecules called immunomodulators can help create more effective vaccines and stronger immunotherapies to treat cancer.

SEC probe of Illumina’s Grail deal targets sales forecasts, sources say

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 14, 2024

Pfizer takes on haemophilia B gene therapy market with new FDA application – Pharmaceutical Technology

Adeno-associated virus gene therapies like Pfizer’s fidanacogene elaparvovec are set to become popular haemophilia treatments. Source: Getty Images / Motortion Pfizer has announced that the

June 27, 2023

House Democrats reiterate call for FDA to work on clinical diversity action plans

Democrats on the House Energy and Commerce committee on Tuesday sent a letter to FDA commissioner Rob Califf requesting the agency give industry more guidance

February 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.